Annex
A


 


THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE
WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL. TRANSFER, ASSIGN,
PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT EXCEPT IN ACCORDANCE WITH APPLICABLE FINRA CONDUCT RULES.


 


VOID
AFTER 5:00 P.M., EASTERN TIME. MARCH 19, 2024.


 


COMMON
STOCK PURCHASE WARRANT


 


For
the Purchase of 153,061 Shares of Common Stock


of


ADVAXIS,
INC.


 


1. Purchase
Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf
of ARATANA THERAPEUTICS, INC. or its assigns (“Holder”),
as registered owner of this Purchase Warrant, to Advaxis, Inc., a Delaware corporation (the “Company”),
Holder is entitled, at any time or from time to time from March 19, 2014 (the
“Commencement Date”), and at or before 5:00 p.m., Eastern time, March 19, 2024 (the
“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up
to 153,061 shares of common stock of the Company, par value $0.001 per share (the
“Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which
banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which
is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not
to take any action that would terminate this Purchase Warrant. This Purchase Warrant is exercisable at $4.90 per Share; provided,
however, that upon the occurrence of any of the events
specified in Section 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number
of Shares to be received upon such exercise, shall be adjusted as therein specified. The term
“Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the
context.


 


2. Exercise.


 


2.1
Exercise Form. In order to exercise this Purchase Warrant,
the exercise form attached hereto as Exhibit I (the
“Notice of Exercise”) must be duly executed and completed and delivered to the Company, together with this
Purchase Warrant and, unless a Cashless Exercise (as defined below) is elected, payment of the Exercise Price for the Shares being
purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check or official bank check. Promptly upon receipt of the Notice of Exercise and the payment of the Exercise Price, if applicable,
and in no event later than three (3) business days thereafter, the Company shall issue to the Holder a certificate for the number
of Shares purchased or, if eligible and permitted by applicable securities laws, deliver such Shares to an account specified by
the Holder through the Deposit Withdrawal at Custodian (DWAC) system of The Depository Trust Company. Subject to Section 2.3 below,
if the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease
and expire.


 




    	D - 15



    	 



    


 


2.2 Cashless
Exercise. Without limiting Section 2.1 above, the Holder of this Warrant may also
exercise this Warrant as to any or all Shares and, in lieu of making the cash payment otherwise contemplated to be made to the
Company upon such exercise in payment of the aggregate Exercise Price, elect instead to receive upon such exercise (a
“Cashless Exercise”) a reduced number of Shares (the
“Net Number”) determined according the following formula:


 


 Net
Number = (AxB) - (AxC)


B


 


For
purposes of the foregoing formula:


 


A
= the total number of shares with respect to which this Purchase Warrant is then being exercised in a Cashless Exercise.


 


B
= the Fair Market Value (as defined below) on the date the Notice of Exercise is delivered to the Company.


 


C
= the Exercise Price then in effect at the time of such Cashless Exercise.


 


“Fair
Market Value” means (a) if the Shares are traded on a securities exchange,
the average of the closing prices over a five (5) trading day period ending three (3) trading days before the day the Fair Market
Value of the Shares is being determined; or (b) if the Shares are traded over-the-counter, the average of the closing bid and
asked prices quoted on the over-the- counter system over the five (5) trading day period ending three (3) trading days before
the day the Fair Market Value of the Shares is being determined.


 


There
cannot be a Cashless Exercise unless “B” exceeds “C”.


 


2.3 Exercise
Prior to Expiration. To the extent this Purchase Warrant is not previously exercised
as to all Shares subject hereto, and if the Fair Market Value of one Share is greater than the Exercise Price then in effect,
this Purchase Warrant shall be deemed to have been automatically exercised by the Holder through a Cashless Exercise immediately
before its expiration. To the extent this Purchase Warrant or any portion thereof is deemed automatically exercised pursuant to
this Section 2.3, the Company agrees to promptly notify the Holder of the number of Shares, if any, the Holder is to receive by
reason of such automatic exercise.


 


2.4 Legend.
Each certificate for the securities purchased under this Purchase Warrant shall bear a legend as follows unless such securities
have been registered under the Securities Act of 1933, as amended (the
“Act”), or counsel for the Company determines that as a result of a Cashless Exercise, such legend is not
required under the Act:


 




    	D - 16



    	 



    


 


“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the
“Act”), or applicable state law. Neither the securities nor any interest therein may be offered for sale,
sold or otherwise transferred except pursuant to an effective registration statement under the Act, or pursuant to an exemption
from registration under the Act and applicable state law which, in the opinion of counsel to the Company, is available.”


 


3. Transfer.


 


3.1 General
Restrictions. Subject to compliance with applicable federal and state securities
laws, this Purchase Warrant and all rights hereunder are transferable, in whole or in part, without charge to the holder hereof
(except for transfer taxes) upon surrender of this Purchase Warrant properly endorsed. In order to make any permitted assignment,
the Holder must deliver to the Company the assignment form attached hereto as Exhibit II duly executed and completed, together
with the Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith. Each taker and holder of
this Purchase Warrant, by taking or holding the same, consents and agrees that this Purchase Warrant, when endorsed in blank,
shall be deemed negotiable, and that the holder hereof, when this Purchase Warrant shall have been so endorsed and its transfer
recorded on the Company’s books, shall be treated by the Company and all other persons dealing with this Purchase Warrant
as the absolute owner hereof for any purpose and as the person entitled to exercise the rights represented by this Warrant. The
Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver
a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase
the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.


 


3.2 Restrictions
Imposed by the Securities Act. The securities evidenced by this Purchase Warrant
shall not be transferred unless and until: (i) the Company has received the opinion of counsel for the Holder that the securities
may be transferred pursuant to an exemption from registration under the Securities Act and applicable state securities laws, the
availability of which is established to the reasonable satisfaction of the Company, or (ii) a registration statement or a post-effective
amendment to the Registration Statement relating to the offer and sale of such securities has been filed by the Company and declared
effective by the U.S. Securities and Exchange Commission (the “Commission”)
and compliance with applicable state securities law has been established.


 


4. New
Purchase Warrants to be Issued.


 


4.1
Partial Exercise or Transfer. Subject to the restrictions
in Section 3 hereof, this Purchase Warrant may be exercised or assigned in whole or in part. In the event of the exercise or assignment
hereof in part only, upon surrender of this Purchase Warrant for cancellation, together with the duly executed exercise or assignment
form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised pursuant to Section 3.1 hereto, the Company
shall cause to be delivered to the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the
name of the Holder evidencing the right of the Holder to purchase the number of Shares purchasable hereunder as to which this
Purchase Warrant has not been exercised or assigned.


 




    	D - 17



    	 



    


 


4.2
Lost Certificate. Upon receipt by the Company of evidence
satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant and of reasonably satisfactory indemnification
or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant of like tenor and date. Any such new Purchase
Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual
obligation on the part of the Company.


 


5.
Adjustments.


 


5.1
Adjustments to Exercise Price and Number of Securities.
The Exercise Price and the number of Shares underlying this Purchase Warrant shall be subject to adjustment from time to time
as hereinafter set forth:


 


5.1.1 Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of
Section 5.3 below, the number of outstanding Shares is increased by a stock dividend payable in Shares or by a split up of Shares
or other similar event, then, on the effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion
to such increase in outstanding Shares, and the Exercise Price shall be proportionately decreased.


 


5.1.2 Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 5.3
below, the number of outstanding Shares is decreased by a consolidation, combination or reclassification of Shares or other similar
event, then, on the effective date thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such
decrease in outstanding Shares, and the Exercise Price shall be proportionately increased.


 


5.1.3 Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other
than a change covered by Section 5.1.1 or 5.1.2 hereof or that solely affects the par value of such Shares, or in the case of
any share recapitalization or amalgamation or consolidation of the Company with or into another corporation (other than a consolidation
or share recapitalization or amalgamation in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding Shares), or in the case of any sale or conveyance to another corporation or entity of the
property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the
Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase
Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such
event, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, share recapitalization or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer,
by a Holder of the number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such
event; and if any reclassification also results in a change in Shares covered by Section 5.1.1 or 5.1.2, then such adjustment
shall be made pursuant to Sections 5.1.1, 5.1.2 and this Section 5.1.3. The provisions of this Section 5.1.3 shall similarly apply
to successive reclassifications, reorganizations, share recapitalizations or amalgamations, or consolidations, sales or other
transfers.


 




    	D - 18



    	 



    


 


5.1.4
Changes in Form of Purchase Warrant. This form of Purchase
Warrant need not be changed because of any change pursuant to this Section 5.1, and Purchase Warrants issued after such change
may state the same Exercise Price and the same number of Shares as are stated in the Purchase Warrants initially issued pursuant
to this agreement. The acceptance by any Holder of the issuance of new Purchase Warrants reflecting a required or permissive change
shall not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.


 


5.2 Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share recapitalization
or amalgamation of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation
which does not result in any reclassification or change of the outstanding Shares), the corporation formed by such consolidation
or share recapitalization or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that
the holder of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration
of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other
securities and property receivable upon such consolidation or share recapitalization or amalgamation, by a holder of the number
of Shares of the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation, share
recapitalization or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall
be identical to the adjustments provided for in this Section 5. The above provision of this Section shall similarly apply to successive
consolidations or share recapitalizations or amalgamations.


 


5.3 Elimination
of Fractional Interests. The Company shall not be required to issue certificates
representing fractions of Shares upon the exercise of this Purchase Warrant, nor shall it be required to issue scrip or pay cash
in lieu of any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding
any fraction up or down, as the case may be, to the nearest whole number of Shares or other securities, properties or rights.


 


6.
Reservation and Listing. The Company shall at all times
reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon exercise of this Purchase Warrant,
such number of Shares or other securities, properties or rights as shall be issuable upon the exercise thereof. The Company covenants
and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor, in accordance with the terms
hereby, all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable
and not subject to preemptive rights of any shareholder. The Company further covenants and agrees that upon exercise of this Purchase
Warrant and payment of the exercise price therefor, all Shares and other securities issuable upon such exercise shall be duly
and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long as this Purchase
Warrant shall be outstanding, the Company shall use its best efforts to cause all Shares issuable upon exercise of this Purchase
Warrant to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable, on the
OTC Bulletin Board or any successor trading market) on which the Shares may then be listed and/or quoted.


 




    	D - 19



    	 



    


 


7.
Certain Notice Requirements.


 


7.1 Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the
Holder the right to vote or consent or to receive notice as a shareholder for the election of directors or any other matter, or
as having any rights whatsoever as a shareholder of the Company. If, however, at any time prior to the expiration of this Purchase
Warrant or its exercise, any of the events described in Section 7.2 shall occur, then, in one or more of said events, the Company
shall give written notice of such event at least fifteen days prior to the date fixed as a record date or the date of closing
the transfer books for the determination of the shareholders entitled to such dividend. distribution, conversion or exchange of
securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale or event
described in Section 5.1.3. Such notice shall specify such record date or the date of the closing of the transfer books, as the
case may be. Notwithstanding the foregoing, the Company shall deliver to the Holder a copy of each notice given to the other shareholders
of the Company at the same time and in the same manner that such notice is given to the shareholders.


 


7.2 Events
Requiring Notice. The Company shall be required to give the notice described in this
Section 7 upon one or more of the following events: (i) if the Company shall take a record of the holders of its Shares for the
purpose of entitling them to receive a dividend or distribution, (ii) the Company shall offer to the holders of its Shares any
additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital stock of
the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the Company
(other than in connection with a consolidation or share recapitalization or amalgamation), any of the events described in Section
5.1.3 or a sale of all or substantially all of its property, assets and business shall be proposed.


 


7.3 Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring
a change in the Exercise Price pursuant to Section 5 hereof, send notice to the Holder of such event and change
(“Price Notice”). The Price Notice shall describe the event causing the change and the method of calculating
same and shall be certified as being true and accurate by the Company’s Chief Financial Officer.


 


7.4 Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase
Warrant shall be in writing and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private
courier service: (i) if to the registered Holder of the Purchase Warrant, to the address of such Holder as shown on the books
of the Company, or (ii) if to the Company, to following address or to such other address as the Company may designate by notice
to the Holder:


 




    	D - 20



    	 



    


 


	If
    to the Holder:
	 
	Aratana
    Therapeutics, Inc.
	1901
    Olathe Boulevard
	Kansas
    City, KS 66103
	Attention:
    Steven St. Peter, President and Chief Executive Officer
	Telephone:
    (913) 951-2133
	Facsimile:
    (913) 904-9641
	 
	With
    a required copy to:
	 
	Latham
    and Watkins
	John
    Hancock Tower, 20th Floor
	200
    Clarendon Street
	Boston,
    MA 02116
	Attention:
    Judith Hasko and Pete Handrinos
	Telephone:
    (617) 948-6000
	Facsimile:
    (617) 948-6001
	 
	If
    to the Company:
	 
	Advaxis,
    Inc.
	305
    College Road East
	Princeton,
    NJ 08540
	Attn:
    Daniel J. O’Connor
	Telephone:
    (609) 452-9813
	Fax
    No.: (609) 452-9818
	 
	with
    a copy (which shall not constitute notice) to:
	 
	Wollmuth,
    Maher & Deutsch LLP
	500
    Fifth Avenue
	New
    York, NY 10110
	Attn:
    Sandip C. Bhattacharji
	Telephone:
    (212) 382-3300
	Fax
    No.: (212) 382-0050


 


8.
Miscellaneous.


 


8.1
Amendments. The Company will not, by amendment of its Certificate
of Incorporation or through any other means, avoid or seek to avoid the observance or performance of any of the terms of this
Purchase Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate in order to protect the rights of the Holder against impairment. All modifications
or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or
amendment is sought. This Purchase Warrant shall be binding upon any successors or assigns of the Company.


 




    	D - 21



    	 



    


 


8.2
Headings. The headings contained herein are for the sole
purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation of any of the terms
or provisions of this Purchase Warrant.


 


8.3.
Entire Agreement. This Purchase Warrant (together with
the other agreements and documents being delivered pursuant to or in connection with this Purchase Warrant) constitutes the entire
agreement of the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings
of the parties, oral and written, with respect to the subject matter hereof.


 


8.4 Severability.
In the event any one or more of the provisions of this Purchase Warrant shall for any reason be held invalid, illegal or unenforceable,
the remaining provisions of this Purchase Warrant shall be unimpaired, and the invalid, illegal or unenforceable provision shall
be replaced by a mutually acceptable valid, legal and enforceable provision, which comes closest to the intention of the parties
underlying the invalid, illegal or unenforceable provision.


 


8.5 Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding
upon, the Holder and the Company and their permitted assignees, respective successors, legal representative and assigns, and no
other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue
of this Purchase Warrant or any provisions herein contained.


 


8.6 Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed
by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws
principles thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any
way to this Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified
mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 7.3 hereof. Such mailing
shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company
and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with
the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right
to trial by jury in any legal proceeding arising out of or relating to this agreement or the transactions contemplated hereby.


 




    	D - 22



    	 



    


 


8.7 Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions
of this Purchase Warrant shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity
of this Purchase Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every
provision of this Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this
Purchase Warrant shall be effective unless set forth in a written instrument executed by the party or parties against whom or
which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed
or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.


 


8.8 Counterparts.
This Purchase Warrant and any amendments, waivers, consents or supplements hereto may be executed in any number of counterparts,
and by different parties hereto in separate counterparts, each of which when so delivered shall be deemed an original, but all
of which counterparts shall constitute but one and the same instrument.


 


8.9 Specific
Performance. The parties hereto hereby declare that it is impossible to measure in
money the damages which will accrue to Holder by reason of the Company’s failure to perform any of the obligations under
this Purchase Warrant and agree that the terms of this Warrant shall be specifically enforceable by Holder. If Holder institutes
any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is brought
hereby waives the claim or defense therein that Holder has an adequate remedy at law, and such person shall not offer in any such
action or proceeding the claim or defense that such remedy at law exists.


 


[Signature
Page Follows]


 




    	D - 23



    	 



    


 


IN WITNESS
WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the 19thday
of March, 2014.


 


	ADVAXIS, INC.	 
	 	 	 
	By:	/s/
    DANIEL J. O’CONNOR	 
	Name:	DANIEL J. O’CONNOR	 
	Title:	PRESIDENT & CEO	 


 




    	D - 24



    	 



    


 


EXHIBIT
I


 


[Form
to be used to exercise Purchase Warrant]


 


Date:
__________, 20__


 


The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for__________________ shares of common stock, par value
$0,001 per share (the “Shares”), of Advaxis,
Inc., a Delaware corporation (the “Company”), and
hereby


 


_______
makes payment of $____________ (at the rate of $________ per Share) in payment of the Exercise Price pursuant thereto or


 


_______
elects to make a Cashless Exercise with respect to________________ Shares.


 


Please
issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.


 


Please
issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.


 


Signature______________________________________



 


Signature
Guaranteed_______________________________ 


 


INSTRUCTIONS
FOR REGISTRATION OF SECURITIES


 


	Name:	 	 
	 	(Print
    in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 


 




    	D - 25



    	 



    


 


DWAC
Instructions (if Company is DWAC eligible at the time of exercise)


 


	 	 	 
	 	 	 
	 	 	 


 


NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by
a firm having membership on a registered national securities exchange.


 




    	D - 26



    	 



    


 


EXHIBIT
II


 


ASSIGNMENT


 


(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):


 


FOR
VALUE RECEIVED, ___________________ does hereby sell, assign and transfer unto ___________________ the right to purchase shares
of common stock, par value $0,001 per share, of Advaxis, Inc., a Delaware corporation (the
“Company”), evidenced by the within Purchase Warrant and does hereby authorize the Company to transfer
such right on the books of the Company.


 


Dated:___________,
20 __


 


Signature______________________________________


 


Signature
Guaranteed_______________________________


 


NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or
by a firm having membership on a registered national securities exchange.




 



    	D - 27